Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Asset Utilization Ratio of 0.29 in Q1 2026, down 0.77% quarter-over-quarter from 0.29 in Q4 2025, and down 2.16% on a YoY basis from 0.29 in Q1 2025.
Assembly Biosciences (ASMB) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Assembly Biosciences' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.29 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 2.16% year-over-year to 0.29; the TTM figure through Mar 2026 stood at 0.29 (down 2.16% YoY), while the FY2025 annual figure was 0.38, up 72.25% from the prior year.
- Asset Utilization Ratio was 0.29 for Q1 2026 at Assembly Biosciences, down from 0.29 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.37 in Q2 2025 to a low of 0.07 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.21 across 4 years, with a median of 0.25 in 2024.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio surged 241.95% in 2024, then retreated 11.76% in 2025.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.08 in 2023, then soared by 241.95% to 0.26 in 2024, then increased by 11.8% to 0.29 in 2025, then decreased by 0.77% to 0.29 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.29 (Q1 2026), 0.29 (Q4 2025), and 0.23 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.29 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.26 |
| Jun 30, 2024 | 0.18 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.08 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.27 |
| Dec 31, 2020 | 0.27 |
| Sep 30, 2020 | 0.28 |
| Jun 30, 2020 | 0.17 |
| Mar 31, 2020 | 0.05 |